In a report released today, Jailendra Singh from Truist Financial maintained a Buy rating on Evolent Health (EVH – Research Report). The ...

Evolent Health faces volatility with missed targets and 2024 guidance cuts. Click here for a full investment analysis of EVH ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Citizens JMP raised the firm’s price target on Evolent Health (EVH) to $13 from $12 and keeps an Outperform rating on the shares. Evolent’s Q4 ...

Your hosts for the call today from Evolent are Seth Blackley, chief executive officer; and John Johnson, chief financial ...

Healthcare solutions company Evolent Health (NYSE:EVH) in Q4 CY2024, but sales rose 16.3% year on year to $646.5 million.

Discover key insights from Evolent Health's Q4 2024 earnings call, focusing on 30% revenue growth, contract renegotiations, projections for 2025, ...

ARLINGTON, Va. (AP) — ARLINGTON, Va. (AP) — Evolent Health Inc. (EVH) on Thursday reported a loss of $22.8 million in its fourth quarter. The Arlington, Virginia-based company said it had a loss of 27 ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...